Table of Contents
What changed
HFL (an Asia Pacific income investment company, figures per the supplied statements) reported a sharp divergence between headline profit and cash flow at HY26.
- Revenue (investment income) rose 63.4% to 20.0m, against 12.2m in HY25.
- PBT jumped 897.8% to 97.2m and NPAT rose 1087.7% to 96.1m, reflecting capital appreciation on the portfolio rather than income alone.
- Operating cash flow was effectively flat at 10.5m versus 10.8m, down 2.9%.
- Cash rose to 25.1m (from 9.3m) but gross borrowings more than doubled to 49.9m (from 23.8m), taking net debt to roughly 24.8m from 14.6m.
- Total assets expanded 49.1% to 584.9m and equity rose 42.9% to 518.9m.
- A second interim dividend of 6.25p per share was declared for the year ending 31 August 2026; this is one component, not the full-period distribution.
What matters
- Profit is portfolio-revaluation driven, not operating-income driven. NPAT rose more than tenfold while cash receipts from investments held steady. The step-up in equity and assets points to capital gains on holdings; the income line alone (+63%) cannot account for the profit move.
- Tax distortion is material, so PBT is the cleaner read. The effective tax rate collapsed to 1.1% from 16.9%, which is consistent with capital-gains treatment in an investment-trust structure but means PBT growth of 897.8% is the more comparable operating measure than NPAT growth of 1087.7%.
- Leverage has stepped up alongside the larger balance sheet. Gross borrowings roughly doubled to 49.9m and net debt rose ~70% to 24.8m. The calculated balance is weakening even as ROE optically improved to 18.5% from 2.2% on the revaluation gains.
Expectations
No quantitative forward guidance or forward-work balance was disclosed in the supplied excerpts, and no explicit targets were provided. The only forward language concerns dividend policy.
Shape context is mixed. HY25 represented just 24.2% of FY25 revenue and 17.9% of FY25 NPAT, so the prior year was second-half weighted. Annualising HY26 revenue gives approximately 40.0m versus the FY25 base of 50.6m, which suggests the income run-rate is currently below last year's full-year figure even as profit surged on valuation gains. The release does not support any read on whether the capital-return component is sustainable into H2.
Quality of result
Durability is limited. Only the 63.4% rise in investment income and the broadly flat ~10.5m of operating cash flow are recurring in nature. The balance of the headline profit reflects unrealised portfolio appreciation that will reverse if markets move against the holdings.
Cash conversion deteriorated materially versus the headline: NPAT grew more than tenfold while OCF was fractionally lower. For an investment company this is expected mechanically — capital gains do not produce cash until realised — but it reinforces that the headline number should not be read as repeatable earnings power.
Capex and company-defined free cash flow were not disclosed in the supplied pages, so a clean FCF reconstruction is not possible. No non-recurring items or non-GAAP adjustments were flagged.
Unresolved
- The split of PBT between revenue return and capital return is not quantified in the supplied excerpts, so the recurring earnings base is opaque.
- Portfolio concentration, country mix, and top-holding exposure are not disclosed here.
- NTA per share is not provided, so valuation ratios (discount/premium to NAV, P/NTA) cannot be computed.
- The full-period dividend total versus just the 6.25p second interim is not resolved.
- The drivers and tenor of the step-up in bank loans to 49.9m, and any gearing policy limit, are not visible.
This briefing cannot assess the market-risk exposure of the portfolio or whether the HY26 revaluation gains have persisted beyond the balance date.
Key metrics
| Metric | HY26 | HY25 | Change |
|---|---|---|---|
| Revenue | $20.0m | $12.2m | +63.4% ↑ |
| Net profit after tax | $96.1m | $8.1m | +1087.7% ↑ |
| Net cash inflow from operating activities | $10.5m | $10.8m | -2.9% ↓ |
| Operating profit | $98.2m | $10.3m | +854.7% ↑ |
| Profit before tax | $97.2m | $9.7m | +897.8% ↑ |
| Cash and cash equivalents | $25.1m | $9.3m | +170.8% ↑ |
| Total assets | $584.9m | $392.3m | +49.1% ↑ |
Reference: annolyse.ai/briefings/hfl-hy26
Analytical metrics
| Metric | HY26 | HY25 | Context |
|---|---|---|---|
| PBT growth | +897.8% | — | cleaner earnings measure |
| Effective tax rate | 1.1% | 16.9% | — |
| Net debt | $24.8m | $14.6m | +$10.2m |
| Gross borrowings | $49.9m | $23.8m | +$26.0m |
| Payout ratio vs NPAT | 12.4% | — | — |
| ROE (annualised) | 18.5% | 2.2% | Strengthening |
| HY25 share of FY25 revenue | 24.2% | — | Other half was 75.8% |
| HY25 share of FY25 NPAT | 17.9% | — | Other half was 82.1% |
| Profit from continuing operations | $96.1m | $8095.0m | −$7998.9m |
Reference: annolyse.ai/briefings/hfl-hy26
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.